A technology provider in the clinical trial patient matching and engagement space, Trialbee has announced a partnership with the global health network, TriNetX.
Trialbee CEO Lollo Eriksson described the partnership as a “great opportunity to leverage both organizations' capabilities to develop new services in order to optimize clinical trials to empower patients with clinical trials as a care option.”
“This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention,” Eriksson said in a statement.
According to the companies, the partnership also will involve work to develop new services aimed at accelerating clinical trials.
“Our collaboration with Trialbee further enhances our health care organizations’ capabilities to streamline patient identification and recruitment. We see this partnership as a complementary effort to our digital developments around protocol design, site identification, and access to patients,” said Maulik Mehta, senior vice president of corporate development at TriNetX.
Based in Cambridge, MA, TriNetX has partnered with health care organizations across 23 countries and thousands of sites, and recently was named as a technology partner in two coordinating centers of the US Food and Drug Administration’s (FDA) Sentinel System.
